Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant.
Korean J Gastroenterol
; 76(5): 242-245, 2020 11 25.
Article
em Ko
| MEDLINE
| ID: mdl-33234771
ABSTRACT
Antiplatelet and anticoagulation agents are increasingly prescribed for secondary prophylaxis in patients with cardiovascular and cerebrovascular diseases. These drugs are associated with an increased risk of gastrointestinal bleeding, including peptic ulcer bleeding. It is difficult to decide when to restart the agents after peptic ulcer bleeding in these patients because the risk of rebleeding and thromboembolism should be balanced. The Korean College of Helicobacter and Upper Gastrointestinal Research revised the guidelines for drug-induced peptic ulcers as evidence-based guidelines using a de novo process. This paper introduces new recommendations on the resumption of antiplatelet and anticoagulation agents after peptic ulcer bleeding based on the revised guidelines for drug-induced peptic ulcers.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Úlcera Gástrica
/
Úlcera Péptica Hemorrágica
/
Úlcera Duodenal
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
Ko
Revista:
Korean J Gastroenterol
Ano de publicação:
2020
Tipo de documento:
Article